Christopher Peetz
CIK 1614740 · CHIEF EXECUTIVE OFFICER · last filed 2026-06-02
Christopher Peetz is a CHIEF EXECUTIVE OFFICER who has filed 51 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for MIRM, was dated Jun 2, 2026. Across all open-market trades the lifetime net is −$18.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $38.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$38.32M
3
51
-$18.05M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MIRM | CHIEF EXECUTIVE OFFICER | 385,686 | $99.34 | $38.32M | -$18.09M | 37 | 2026-06-02 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Director | 0 | $64.97 | $0 | $38.6K | 10 | 2024-05-20 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Chief Financial Officer | — | — | — | $0 | 3 | 2016-01-14 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | MIRM | Mixed | — | -$2.79M | EDGAR |
| 2026-03-17 | MIRM | Mixed | +34,015 | -$3.77M | EDGAR |
| 2026-02-03 | MIRM | Sell (S) | −9,108 | -$940.9K | EDGAR |
| 2026-01-30 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2026-01-27 | MIRM | Mixed | +5,669 | -$657.1K | EDGAR |
| 2026-01-23 | MIRM | Mixed | +5,699 | -$662.4K | EDGAR |
| 2026-01-02 | MIRM | Gift (G) | −21,070 | $0 | EDGAR |
| 2025-11-20 | MIRM | Exer (M) | +19,133 | $368.1K | EDGAR |
| 2025-08-12 | MIRM | Mixed | — | -$2.36M | EDGAR |
| 2025-08-08 | MIRM | Mixed | — | -$2.09M | EDGAR |